| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K71781559 |
| PharmacoGx | BRD-K71781559 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CYB561D2 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.09 |
| mRNA | TSG101 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.09 |
| mRNA | PSME1 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.09 |
| mRNA | KRT3 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | PIM2 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.09 |
| mRNA | AVEN | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |
| mRNA | WARS2 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | JMJD4 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |
| mRNA | CEP131 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.09 |
| mRNA | OR9K2 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
